Abstract
Angiotensin II (Ang II) reportedly enhances regulator of G-protein signaling 2 (RGS2), thus making a negative feedback loop for Ang II signal transduction. However, few studies have reported whether Ang II receptor (ATR) antagonists influence RGS2 mRNA expression. We investigated RGS2 mRNA expression when Ang II binding to ATR was blocked with Ang II subtype-1 receptor (AT1R) blockers using vascular smooth muscle cells from the thoracic aorta of male Wistar rats. RGS2 mRNA expression significantly increased with Ang II stimulation, and this increase was almost completely abolished by olmesartan, a potent AT1R-specific blocker. Ang II subtype-2 receptor (AT2R) was not involved in Ang II-mediated RGS expression. In contrast, the AT1R blocker, losartan, partially decreased Ang II-mediated RGS2 mRNA expression because this antagonist directly stimulated RGS2 mRNA expression in Ang II-free medium. EXP3174, which is an active metabolite of losartan, almost completely blunted Ang II-mediated RGS2 mRNA expression without direct stimulation of RGS2 mRNA expression. Moreover, pretreatment with olmesartan abolished Ang II-mediated RGS2 mRNA expression. Treatment with a protein kinase C inhibitor partially decreased losartan-mediated RGS2 ...Continue Reading
References
Jan 1, 1995·Journal of Hypertension·N HirawaT Toyo-oka
May 1, 1996·Drugs·K L Goa, A J Wagstaff
Jan 1, 1997·Hypertension·K K GriendlingR W Alexander
Jul 25, 1998·The Journal of Biological Chemistry·M Ushio-FukaiR W Alexander
Apr 1, 1999·The New England Journal of Medicine·Z FarfelT Iiri
Feb 29, 2000·Molecular Pharmacology·S L GrantR W Alexander
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·L De VriesM G Farquhar
Mar 22, 2002·The International Journal of Biochemistry & Cell Biology·John H Kehrl, Srikumar Sinnarajah
Apr 20, 2002·Circulation Research·Junichi Sadoshima
Apr 20, 2002·Circulation Research·Christine KrämerBernhard Schieffer
Jun 22, 2002·Drugs·Gregory T Warner, Blair Jarvis
Feb 18, 2003·The Journal of Clinical Investigation·Scott P HeximerKendall J Blumer
Jun 18, 2003·Clinical Therapeutics·Julie A Brousil, John M Burke
Jan 7, 2004·Circulation·Bernard I Lévy
Aug 30, 2005·American Journal of Hypertension·Bernard I Levy
Sep 21, 2005·Circulation·Tetsu WatanabeBradford C Berk
May 11, 2006·Journal of Hypertension·Andrea SempliciniAchille C Pessina
Jul 18, 2006·Cellular Signalling·Graham LaddsJohn Davey
Nov 4, 2006·Biochimica Et Biophysica Acta·Paul A InselMartin C Michel
Feb 6, 2007·Current Opinion in Pharmacology·Thomas WielandPeter Chidiac
Jul 7, 2007·The Journal of Biological Chemistry·Zhongwen XieZhenheng Guo
Aug 8, 2007·The Journal of Biological Chemistry·Patrick Osei-OwusuKendall J Blumer
Apr 10, 2008·Journal of Hypertension·Lorenzo A CalòAchille C Pessina
Apr 16, 2008·European Journal of Pharmacology·Mariëlle C Hendriks-BalkAstrid E Alewijnse
Aug 19, 2009·Hypertension·Kai KappertUlrich Kintscher
Aug 19, 2009·Hypertension·Ana FortuñoGuillermo Zalba
May 9, 2014·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Chonglong WuZhice Xu
May 23, 2015·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Giuseppe DerosaPamela Maffioli
Nov 27, 2015·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yaqiong WuYoshio Uehara